Industry: Chemical & Material
Published Date: 2026-03-09
Pages: 100 Pages
Report ld: 6063314
Request Sample
Customized Report
Tigecycline Hydrate Market Size(US$)

CAGR 2026-2032
6.8%
Market Size,2032
USD 1,048
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Tigecycline Hydrate market size was US$ 668 million in 2025 and is forecast to reach a readjusted size of US$ 1048 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
In 2024, global sales of tigecycline hydrate reached 37 tons, with an average selling price of US$16,853 per kilogram.
Tigecycline hydrate is a crystalline hydrate form of tigecycline, a broad-spectrum, intravenous glycylcyclic peptide antibiotic belonging to the third-generation tetracycline class. Tigecycline hydrate offers improved storage stability and can be used to prepare drugs for the treatment or prevention of various Gram-positive or Gram-negative bacterial infections, such as those of the respiratory system, hepatobiliary system, bone and joint, skin and soft tissue, as well as sepsis and meningitis.
Tigecycline hydrate (hydrochloride monohydrate) is currently the only marketed powder for injection.
Tigecycline hydrate is primarily produced through semi-synthetic fermentation and chemical coupling (minocycline is first fermented, followed by 3-4 steps to synthesize tigecycline). Leading companies have achieved GMP-grade, large-scale production with >99% purity and <0.1% impurities.
Tigecycline hydrate faces a challenging market characterized by high technological barriers and environmental pressures. Its core competitive factors are registration documents (DMF/CEP), green processes, and economies of scale. Over 90% of downstream sales go to injectables. Prices are squeezed by centralized procurement and capacity cycles, and are expected to fall 15-20% from their peak in 2024. In the short term, volume will continue to drive price. In the medium and long term, process optimization, by-product recovery, and orders from emerging markets will be crucial for maintaining profitability.
The global Tigecycline Hydrate market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Tigecycline Hydrate sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Tigecycline Hydrate manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Tigecycline Hydrate product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tigecycline Hydrate value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Tigecycline Hydrate Product Scope
1.2 Tigecycline Hydrate by Type
1.2.1 Global Tigecycline Hydrate Sales by Type (2021, 2025 & 2032)
1.2.2 Direct Acylation Method
1.2.3 Amination Method
1.3 Tigecycline Hydrate by Application
1.3.1 Global Tigecycline Hydrate Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Medicine
1.3.3 Chemical
1.3.4 Others
1.4 Global Tigecycline Hydrate Market Estimates and Forecasts (2021-2032)
1.4.1 Global Tigecycline Hydrate Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Tigecycline Hydrate Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Tigecycline Hydrate Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Tigecycline Hydrate Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Tigecycline Hydrate Historical Market Scenario by Region (2021-2026)
2.2.1 Global Tigecycline Hydrate Sales Market Share by Region (2021-2026)
2.2.2 Global Tigecycline Hydrate Revenue Market Share by Region (2021-2026)
2.3 Global Tigecycline Hydrate Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Tigecycline Hydrate Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Tigecycline Hydrate Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Tigecycline Hydrate Market Size and Prospects (2021-2032)
2.4.2 Europe Tigecycline Hydrate Market Size and Prospects (2021-2032)
2.4.3 China Tigecycline Hydrate Market Size and Prospects (2021-2032)
2.4.4 Japan Tigecycline Hydrate Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Tigecycline Hydrate Historical Market Review by Type (2021-2026)
3.1.1 Global Tigecycline Hydrate Sales by Type (2021-2026)
3.1.2 Global Tigecycline Hydrate Revenue by Type (2021-2026)
3.1.3 Global Tigecycline Hydrate Average Price by Type (2021-2026)
3.2 Global Tigecycline Hydrate Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Tigecycline Hydrate Sales Forecast by Type (2027-2032)
3.2.2 Global Tigecycline Hydrate Revenue Forecast by Type (2027-2032)
3.2.3 Global Tigecycline Hydrate Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Tigecycline Hydrate
4 Global Market Size by Application
4.1 Global Tigecycline Hydrate Historical Market Review by Application (2021-2026)
4.1.1 Global Tigecycline Hydrate Sales by Application (2021-2026)
4.1.2 Global Tigecycline Hydrate Revenue by Application (2021-2026)
4.1.3 Global Tigecycline Hydrate Average Price by Application (2021-2026)
4.2 Global Tigecycline Hydrate Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Tigecycline Hydrate Sales Forecast by Application (2027-2032)
4.2.2 Global Tigecycline Hydrate Revenue Forecast by Application (2027-2032)
4.2.3 Global Tigecycline Hydrate Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Tigecycline Hydrate Applications
5 Competition Landscape by Players
5.1 Global Tigecycline Hydrate Sales by Player (2021-2026)
5.2 Global Top Tigecycline Hydrate Players by Revenue (2021-2026)
5.3 Global Tigecycline Hydrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Tigecycline Hydrate revenue as of 2025
5.4 Global Tigecycline Hydrate Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Tigecycline Hydrate, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Tigecycline Hydrate, Product Type & Application
5.7 Global Key Manufacturers of Tigecycline Hydrate, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Tigecycline Hydrate Sales by Company
6.1.1.1 North America Tigecycline Hydrate Sales by Company (2021-2026)
6.1.1.2 North America Tigecycline Hydrate Revenue by Company (2021-2026)
6.1.2 North America Tigecycline Hydrate Sales Breakdown by Type (2021-2026)
6.1.3 North America Tigecycline Hydrate Sales Breakdown by Application (2021-2026)
6.1.4 North America Tigecycline Hydrate Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Tigecycline Hydrate Sales by Company
6.2.1.1 Europe Tigecycline Hydrate Sales by Company (2021-2026)
6.2.1.2 Europe Tigecycline Hydrate Revenue by Company (2021-2026)
6.2.2 Europe Tigecycline Hydrate Sales Breakdown by Type (2021-2026)
6.2.3 Europe Tigecycline Hydrate Sales Breakdown by Application (2021-2026)
6.2.4 Europe Tigecycline Hydrate Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Tigecycline Hydrate Sales by Company
6.3.1.1 China Tigecycline Hydrate Sales by Company (2021-2026)
6.3.1.2 China Tigecycline Hydrate Revenue by Company (2021-2026)
6.3.2 China Tigecycline Hydrate Sales Breakdown by Type (2021-2026)
6.3.3 China Tigecycline Hydrate Sales Breakdown by Application (2021-2026)
6.3.4 China Tigecycline Hydrate Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Tigecycline Hydrate Sales by Company
6.4.1.1 Japan Tigecycline Hydrate Sales by Company (2021-2026)
6.4.1.2 Japan Tigecycline Hydrate Revenue by Company (2021-2026)
6.4.2 Japan Tigecycline Hydrate Sales Breakdown by Type (2021-2026)
6.4.3 Japan Tigecycline Hydrate Sales Breakdown by Application (2021-2026)
6.4.4 Japan Tigecycline Hydrate Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Pfizer Tigecycline Hydrate Products Offered
7.1.5 Pfizer Recent Development
7.2 Teva
7.2.1 Teva Company Information
7.2.2 Teva Business Overview
7.2.3 Teva Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Teva Tigecycline Hydrate Products Offered
7.2.5 Teva Recent Development
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Company Information
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Sun Pharmaceutical Tigecycline Hydrate Products Offered
7.3.5 Sun Pharmaceutical Recent Development
7.4 Olon S.p.A
7.4.1 Olon S.p.A Company Information
7.4.2 Olon S.p.A Business Overview
7.4.3 Olon S.p.A Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Olon S.p.A Tigecycline Hydrate Products Offered
7.4.5 Olon S.p.A Recent Development
7.5 Rochem International
7.5.1 Rochem International Company Information
7.5.2 Rochem International Business Overview
7.5.3 Rochem International Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Rochem International Tigecycline Hydrate Products Offered
7.5.5 Rochem International Recent Development
7.6 Mac-Chem Products
7.6.1 Mac-Chem Products Company Information
7.6.2 Mac-Chem Products Business Overview
7.6.3 Mac-Chem Products Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Mac-Chem Products Tigecycline Hydrate Products Offered
7.6.5 Mac-Chem Products Recent Development
7.7 Melody Healthcare
7.7.1 Melody Healthcare Company Information
7.7.2 Melody Healthcare Business Overview
7.7.3 Melody Healthcare Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Melody Healthcare Tigecycline Hydrate Products Offered
7.7.5 Melody Healthcare Recent Development
7.8 Hisun Pharmaceutical
7.8.1 Hisun Pharmaceutical Company Information
7.8.2 Hisun Pharmaceutical Business Overview
7.8.3 Hisun Pharmaceutical Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Hisun Pharmaceutical Tigecycline Hydrate Products Offered
7.8.5 Hisun Pharmaceutical Recent Development
7.9 Fuan Pharmaceutical
7.9.1 Fuan Pharmaceutical Company Information
7.9.2 Fuan Pharmaceutical Business Overview
7.9.3 Fuan Pharmaceutical Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Fuan Pharmaceutical Tigecycline Hydrate Products Offered
7.9.5 Fuan Pharmaceutical Recent Development
7.10 Wuhan QR Pharmaceuticals
7.10.1 Wuhan QR Pharmaceuticals Company Information
7.10.2 Wuhan QR Pharmaceuticals Business Overview
7.10.3 Wuhan QR Pharmaceuticals Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Wuhan QR Pharmaceuticals Tigecycline Hydrate Products Offered
7.10.5 Wuhan QR Pharmaceuticals Recent Development
7.11 Sailong Pharmaceutical Group
7.11.1 Sailong Pharmaceutical Group Company Information
7.11.2 Sailong Pharmaceutical Group Business Overview
7.11.3 Sailong Pharmaceutical Group Tigecycline Hydrate Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Sailong Pharmaceutical Group Tigecycline Hydrate Products Offered
7.11.5 Sailong Pharmaceutical Group Recent Development
8 Tigecycline Hydrate Manufacturing Cost Analysis
8.1 Tigecycline Hydrate Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Tigecycline Hydrate
8.4 Tigecycline Hydrate Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Tigecycline Hydrate Distributors List
9.3 Tigecycline Hydrate Customers
10 Tigecycline Hydrate Market Dynamics
10.1 Tigecycline Hydrate Industry Trends
10.2 Tigecycline Hydrate Market Drivers
10.3 Tigecycline Hydrate Market Challenges
10.4 Tigecycline Hydrate Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Tigecycline Hydrate was estimated to be worth US$ 668 million in 2025 and is projected to reach US$ 1048 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 112
USD 3950.00
(Single User License)
The global Tigecycline Hydrate market was valued at US$ 668 million in 2025 and is anticipated to reach US$ 1048 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 142
USD 2900.00
(Single User License)
The global Tigecycline Hydrate market size was US$ 635 million in 2024 and is forecast to a readjusted size of US$ 988 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 98
USD 4250.00
(Single User License)
The global Tigecycline Hydrate market is projected to grow from US$ 635 million in 2024 to US$ 988 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 164
USD 4900.00
(Single User License)
The global market for Tigecycline Hydrate was estimated to be worth US$ 635 million in 2024 and is forecast to a readjusted size of US$ 988 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-10-24
Pages: 129
USD 3950.00
(Single User License)
The global market for Tigecycline Hydrate was valued at US$ 635 million in the year 2024 and is projected to reach a revised size of US$ 988 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-10-24
Pages: 103
USD 2900.00
(Single User License)
The global market for Tigecycline Hydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 93
USD 3950.00
(Single User License)
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Published Date: 2024-04-12
Pages: 92
USD 4900.00
(Single User License)
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Published Date: 2024-01-17
Pages: 88
USD 2900.00
(Single User License)
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Published Date: 2024-01-07
Pages: 94
USD 3950.00
(Single User License)
The global market for Tigecycline Hydrate was estimated to be worth US$ 668 million in 2025 and is projected to reach US$ 1048 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-03-06
Pages: 112
The global Tigecycline Hydrate market was valued at US$ 668 million in 2025 and is anticipated to reach US$ 1048 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-03-06
Pages: 142
The global Tigecycline Hydrate market size was US$ 635 million in 2024 and is forecast to a readjusted size of US$ 988 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 98
The global Tigecycline Hydrate market is projected to grow from US$ 635 million in 2024 to US$ 988 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 164
The global market for Tigecycline Hydrate was estimated to be worth US$ 635 million in 2024 and is forecast to a readjusted size of US$ 988 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-10-24
Pages: 129
The global market for Tigecycline Hydrate was valued at US$ 635 million in the year 2024 and is projected to reach a revised size of US$ 988 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-10-24
Pages: 103
The global market for Tigecycline Hydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 93
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Published: 2024-04-12
Pages: 92
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Published: 2024-01-17
Pages: 88
Tigecycline is bacteriostatic and is a protein synthesis inhibitor by binding to the 30S ribosomal subunit of bacteria and thereby blocking entry of Aminoacyl-tRNA into the A site of the ribosome during prokaryotic translation.
Published: 2024-01-07
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now